Scroll
A Customer-centric, Innovative
and Reliable CDMO with Global Solutions
One-stop Services and Solutions
Small Molecules CDMO Services
Delivers full‑scope CMC solutions for small‑molecule drug programs.
More
TIDES CDMO Services
Provides comprehensive services for peptide drugs and small nucleic acid drugs.
More
Biologics and Conjugates CDMO Services
Delivers comprehensive solutions for biologic molecules and conjugate therapeutics (ADC, AOC, DAC, PDC, RDC).
More
Advanced Therapy Medicinal Products CRO & CDMO Services
Provides end-to-end CRO and CDMO services platform, including cell banking, process development, analytical development, GMP manufacturing, fill & finish, and testing services for plasmids, viral vectors, cell therapy, bacterial vector and nucleic acid therapeutics.
More
Global Presence
Global Presence
China
-
Chongqing
Headquarters, R&D Center
R&D and GMP Manufacturing
HP, DS & DP -
Shanghai
Headquarters, R&D Center
R&D and GMP Manufacturing
HP, DS & DP
TIDES
Biologics and Conjugates
Yichun, Jiangxi
GMP Manufacturing, RSM & INT
Xiaogan, Hubei
Manufacturing, RSM & INT
Suzhou, Jiangsu
R&D and GMP Manufacturing
ATMP
Switzerland
America
Environmental, Social and Corporate Governance
At Porton, we are guided by the ESG principles of green development, promoting common progress, building a healthy society together, and enhancing corporate governance. These principles drive our sustainable development and our efforts to create greater environmental and social value.
News
Sep 17, 2026
Porton Congratulates Partner Acepodia on FDA Clearance of IND Application for ACE723, a Dual-Payload ADC
Sep 15, 2026
Porton Chongqing Liangjiang Drug Product Manufacturing Site Earns Recertification of ISO 14001 & ISO 45001
Sep 01, 2026
Porton to Showcase End-to-End CDMO Expertise at CPHI Milan 2026
